Haleon plc (NYSE:HLN) Receives Average Rating of "Hold" from Brokerages

Shares of Haleon plc (NYSE:HLN - Get Free Report) have been assigned a consensus recommendation of "Hold" from the eight analysts that are presently covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold recommendation, one has given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $10.95.

Several brokerages recently issued reports on HLN. HSBC reiterated a "hold" rating on shares of Haleon in a research note on Wednesday, March 5th. Sanford C. Bernstein cut Haleon from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 8th. Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Morgan Stanley lowered shares of Haleon from an "overweight" rating to an "equal weight" rating in a report on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Haleon in a research report on Monday, March 3rd.

Haleon Stock Performance

HLN opened at $10.22 on Monday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The business has a fifty day simple moving average of $10.09 and a 200 day simple moving average of $9.80. Haleon has a 1 year low of $8.12 and a 1 year high of $10.80. The company has a market capitalization of $46.16 billion, a PE ratio of 30.06, a price-to-earnings-growth ratio of 2.82 and a beta of 0.24.

Haleon (NYSE:HLN - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Research analysts expect that Haleon will post 0.43 EPS for the current year.

Haleon Increases Dividend

The firm also recently announced a -- dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be paid a dividend of $0.1166 per share. This is an increase from Haleon's previous -- dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. This represents a yield of 1.6%. Haleon's payout ratio is presently 58.97%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Sierra Ocean LLC bought a new position in Haleon in the 4th quarter valued at approximately $26,000. Opal Wealth Advisors LLC bought a new position in shares of Haleon in the 1st quarter valued at $29,000. Versant Capital Management Inc boosted its holdings in shares of Haleon by 2,029.1% during the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company's stock valued at $34,000 after acquiring an additional 3,348 shares in the last quarter. Geneos Wealth Management Inc. bought a new stake in Haleon during the 4th quarter worth $35,000. Finally, FIL Ltd increased its holdings in Haleon by 45.7% in the 4th quarter. FIL Ltd now owns 4,049 shares of the company's stock worth $39,000 after purchasing an additional 1,270 shares in the last quarter. Institutional investors own 6.67% of the company's stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.